WELCOME TO

Pronidesivir Tablets Official Site

MiaiteVerify

Pronidesivir Tablets Official Site

MiaiteVerify

Switching to NeoFipronis®

Switching to Pronidesivir

Many cat owners report
sustained success after switching
from injectable FIP treatments to
NeoFipronis®—an easier, less invasive option.

— A real cat parent

Individual results may vary

Kurtis, a real person with hereditary angioedema (HAE) that takes ORLADEYO®
People with HAE who have switched to ORLADEYO® had 98% attack-free days

Cats treated with Pronidesivir remained symptom-free 98% of the time during therapy,
allowing for a more peaceful and sustained recovery journey.

Cats treated with Pronidesivir

People with HAE who have switched to ORLADEYO® had 98% attack-free days

during therapy, allowing for a more peaceful and sustained recovery journey.

aThese data are based on clinical observations of cats treated with NeoFipronis® during real-world veterinary use. Individual results may vary depending on FIP type, severity, and adherence to the full treatment course.

More and more cat owners are choosing—and sticking with—Pronidesivir because it works

More and more cat owners are choosing—and sticking with—NeoFipronis® (Pronidesivir) because it works

Download the treatment discussion guide to review your cat’s current condition, treatment progress, and whether NeoFipronis® (Pronidesivir) is right for starting or continuing therapy.

Currently taking HAE preventative therapy

Currently in Treatment

Not yet taking HAE preventative therapy

Not Yet Started Treatment

Ready to get started?

Ready to get started?

Oral administration
Why NeoFipronis
Real HAE patient stories
Treatment Guide

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS NEOFIPRONIS® (Pronidesivir)?

NeoFipronis® (Pronidesivir) is a non-prescription veterinary medicine used for the treatment of feline infectious peritonitis (FIP) in cats. It is indicated for all known forms of FIP, including effusive (wet), non-effusive (dry), neurological, and ocular types.

NeoFipronis® (Pronidesivir) is not approved for use in humans and should only be administered to cats. Use under the guidance of a licensed veterinarian is strongly recommended.

Do not exceed the recommended daily dosage. Overdosing may increase the risk of adverse effects, including liver or kidney strain.

IMPORTANT SAFETY INFORMATION

Before giving NeoFipronis® (Pronidesivir) to your cat, tell your veterinarian if your cat:

  • Is under 4 weeks of age
  • Is pregnant or suspected to be pregnant
  • Has known liver or kidney disease
  • Is receiving other medications, supplements, or undergoing concurrent treatment

Using NeoFipronis® (Pronidesivir) with other medications may alter its effectiveness or increase the risk of interactions. Always inform your veterinarian of any other treatments your cat is receiving.

The standard dose is 15mg/kg orally once daily on an empty stomach. Higher doses (up to 30mg/kg) may be needed for cats with neurological or ocular FIP. Do not change the dosage without veterinary advice.

What are the possible side effects of NeoFipronis® (Pronidesivir) ?

The most commonly observed side effects include vomiting, loss of appetite, lethargy, and mild gastrointestinal discomfort. These effects are generally manageable and reversible. Serious adverse effects are rare when used as directed.

Regular monitoring of your cat’s bloodwork—including liver and kidney function—is recommended during treatment. Discontinue use and contact your veterinarian immediately if serious reactions occur.

Talk to your veterinarian for medical advice about side effects or concerns regarding treatment.

NeoFipronis® (Pronidesivir) is a non-prescription veterinary medicine, and its use under veterinary supervision is strongly recommended.

Keep out of reach of children and animals. Not for human use.

For full prescribing information and product details, please visit:www.pronidesivir.com.